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Hemeoxygenase-I(HO-1)hasemergedasoneofthemostprotectiveenzymesanditspleiotropicactivitieshavebeendemonstrated
in a variety of human pathologies. Unpublished observations have shown that HO-1 is induced after the infusion of ozonated
blood into the respective donors, and many other experimental observations have demonstrated the eﬃcacy of oxidizing agents.
It appeared worthwhile to evaluate whether we could better deﬁne the activity of potential inducers such as hydrogen peroxide
and ozonated human plasma. Human vascular endothelial cells at conﬂuence were challenged with diﬀerent concentrations of
these inducers and the simultaneous production of nitric oxide (NO); and HO-1 was measured by either measuring nitrite, or
bilirubin formation, or/and the immune reactivity of the protein by Western blot using a rabbit antihuman HO-1 and Hsp-70.
The results show that production of both NO and HO-1 is fairly dose dependent but is particularly elevated using human plasma
after transient exposure to a medium ozone concentration. At this concentration, there is also induction of Hsp-70. The results
clarify another positive eﬀect achievable by the use of ozone therapy.
Copyright © 2007 Velio Bocci et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Heme oxygenase-1 (HO-1) has been deﬁned as a cellular
Hercules [1] because of its potent and pleiotropic biologi-
cal activities. After Tenhunen et al., in 1972, published the
ﬁrst report describing the enzymatic degradation of heme
[2], the interest in this enzyme has grown exponentially and
to our knowledge, today there are almost 4000 publications
on this topic. The induction of HO-1, mainly considered
a generalized response to oxidative stress, results in an in-
creased formation of carbon monoxide (CO) and biliru-
bin while redox-active iron is rapidly and safely sequestered
by the simultaneous coinduction of ferritin [3]. Amazingly,
bilirubin, thought to be always a useless and possibly a toxic
molecule, has revealed to be an excellent lipophilic antiox-
idant, far more eﬀective than reduced glutathione [4]. CO,
a well-known deadly gas molecule, when released in trace
amounts, appears to be cytoprotective because of its cyclic-
GMP-mediatedmodulationofvasculartoneandneurotrans-
mission [5]. Thus, it is not surprising that HO-1 has been
shown to prevent or improve pathological states associated
with cardiomyopathy, chronic limb ischemia, hypertension,
endotoxemia, organ transplantation, chronic infections, pul-
monary diseases, diabetes, and autoimmune diseases [6–8].
Inallofthesecases,theinitialetiologicalcauseisperpetuated
by a chronic oxidative stress that tends to accelerate the pro-
gression of the disease. Orthodox medicine has several valid
drugs that, rather than “curing” the disease, aim to stabilize
it. A supplemental administration of antioxidants is harm-
less, but it is of little help [9] because the main problem is
the intracellular unbalance between an excessive production
of reactive oxygen species (ROS), peroxidation products, and
proinﬂammatory cytokines in front of the reduced eﬃciency
of the antioxidant system.
During the last decade, our biological and clinical work
[10–14] has shown that a judiciously performed ozone ther-
apyinstillresponsivepatientsisabletocorrectthisabnormal
situation by upregulating antioxidant enzymes such as SOD,
GSH-peroxidases, reductases and transferases, and glucose-
6-phosphatedehydrogenase.Thisresult,ﬁrstlydemonstrated
for SOD in 1996 [15], is due to the repetition of small and
acute oxidative stresses induced by precise doses of well-
calibrated ozone against the potent antioxidant capacity of
human blood. This process, now universally present from
bacteria to fungi, plants, and mammals, has been deﬁned as
an adaptation to acute oxidative stresses or oxidative precon-
ditioning [10–12, 15, 16]. Moreover, this apparently para-
doxical biological eﬀect has been postulated [10–12]t ob e2 Mediators of Inﬂammation
supported by the simultaneous induction of HO-1 because
this enzyme is induced by hydrogen peroxide (H2O2), ultra-
violet radiation, ROS [17], and by heme [6]. During the few
minutes of ozonation of human blood ex vivo; ozone dis-
solves in the plasmatic water and generates messengers such
as H2O2 and lipid oxidation products (LOPs) which, after
the prompt reinfusion of the ozonated blood in the donor,
are responsible of the several biological eﬀects, of which an
important one is the upregulation of the antioxidant system
intuitively explained as a defensive reaction.
Owing to the fact that ozone therapy, besides behaving as
acalculatedacuteoxidativestress,favorsthereleaseofasmall
amount of hemoglobin, it appears reasonable to envisage the
subsequent induction of HO-1 in the donor patient. On this
basis, we have performed the following preliminary study to
ascertain whether potential HO-1 inducers can stimulate the
synthesis of this enzyme in human endothelial cells.
2. MATERIALS AND METHODS
2.1. Chemicals
Sodium nitrite (NaNO2), H2O2 (30% solution), L-arginine,
and the NO synthase inhibitor NG-nitro-L-arginine methyl
ester (L-NAME) were purchased from Sigma Chemical and
Aldrich Chemical (MO, USA). Hemin was dissolved in 10%
ammonium hydroxide in 0.15M NaCl to prepare a stock so-
lutionof100mg/mLandthenfurtherdiluted1:40withster-
ile 0.15M NaCl (2.5μg/1μL).
2.2. Ozonegenerationandmeasurement
Ozone was generated from medical-grade oxygen (O2) using
electrical corona arc discharge, by the O3 generator (Model
Ozonosan PM100K, Hansler. GmbH, Iﬀezheim, Germany),
w h i c ha l l o w st h eg a sﬂ o wr a t ea n dO 3 concentration to be
controlledinrealtime byphotometric determination, asrec-
ommended by the Standardisation Committee of the Inter-
national O3 Association. The ozone ﬂow rate was kept con-
stant at 3L/min in all experiments. Polypropylene syringes
(ozone-resistant) were used throughout the reaction proce-
dure to ensure containment of O3 and consistency in con-
centrations.
2.3. Collectionofhumanbloodandplasmasamples
Blood samples were taken from one of us in the morning by
using calciparin (20U/mL blood) as an anticoagulant. Each
blood sample of 20.0mL, contained in a 50mL syringe, was
immediately treated with the gas mixture composed of a vol-
umeof20.0mLofagasmixturecomposedofO2(∼96%)and
O3(∼4%), at the ozone concentrations indicated in Table 1.
The gas withdrawn in a 20mL syringe was introduced into
the 50mL syringe containing the blood sample via a mul-
tidirectional stopcock. We have previously determined that
a rapid rotation of the syringe along its longitudinal axis
(about 80cycles/min) for one minute achieved a complete
mixing of the liquid-gas phases with minimal foaming and
that, within this period of time, ozone reacts completely with
substrates, implying that blood samples receiving ozone re-
act with the ozone dose totally. The pO2 reached a value of
about 400mm Hg, while the blood pCO2 and pH values did
not change. In order to obtain reproducible results, it needs
to be emphasized that O3 is a very reactive gas meaning that
anextremelyrapidandprecisehandlingisrequired.Theﬁnal
gas pressure remained at normal atmospheric pressure. Con-
trol sample received only oxygen. Immediately after either
the oxygenated or the ozonated samples were centrifuged at
3500g for 7minutes, the separated plasma was promptly dis-
tributed in cell culture dishes.
2.4. Cellcultureandincubations
Primary human endothelial cells (HUVECs) were obtained
from the neonatal umbilical cord vein as previously de-
scribed [18]. Endothelial cell growth medium (EGM) with
theappropriatesupplementsandothernecessarymediawere
obtained from Clonetics (San Diego, Calif, USA). For tissue
culture procedures, in terms of initiation, subculturing and
maintenance, we followed the indications given by Cambrex
Inc. (LA, USA). Cells were grown in a humidiﬁed incuba-
tor at 37◦C (95% room air, 5% CO2, pH 7.3) within 3–4
days after growth to conﬂuence. When nitrite measurements
were performed, cells were transferred to 24 well (2cm2)t i s -
sue culture plates and were used at the same cell density and
passage number [18].
2.5. Biochemicaldeterminations
Hydrogen peroxide (H2O2) was measured in plasma before
andafteradditionofoxygen-ozonebytheenzymaticmethod
describedbyGreenandHill[19].Proteinthiolgroups(PTG)
were measured in plasma according to Hu [20] using proce-
dure 1 with 5,5 -dithiobis (2-nitrobenzoic acid, DTNB) dis-
solved in absolute methanol. The thiobarbituric acid (TBA)
assay was carried out in plasma as described by Buege and
Aust [21]. Values are expressed as μMo fT B Ar e a c t i v es u b -
stances (TBARS) relative to a malondialdehyde standard.
Productionofnitriteconcentrationswasmeasuredinculture
medium supernatants after the addition of predetermined
inducers, by using the Griess reagent as previously described
[18, 22]. The colored product was spectrophotometrically
determined at 538nm. Nitrite concentration (μM) was de-
termined by comparison with a standard curve made from a
solution of NaNO2.
2.6. Biochemicalandimmunologicalassaysfor
endothelialhemeoxygenaseactivity
Conﬂuent HUVECs in 75 cm2 ﬂasks were incubated for
18 hours in EGM (alone for the control group) or in the
presence of several HO-1 inducers as follows: H2O2 (from
20 to 200μM), porcine hematin (2.5mg/mL saline) HO-
1 activity assay. The enzymatic activity was measured by
bilirubin generation as described by Motterlini et al. [23]
with minimal modiﬁcations. HUVECs were grown to con-
ﬂuence in 10cm tissue culture dishes and then were incu-
bated for 18 hours in EGM (ﬁnal volume 10mL, controlVelio Bocci et al. 3
Table 1: Production of NO (as total nitrite, μM) and HO-1 (as bilirubin, pmol/mg cell protein/1 hour) after stimulation of HUVECs in
culture for 18 hours with the indicated inducers.
Inducers NO HO-1 As a % increase of HO-1
Medium 1.3 80 100
Medium + O2 1.4 86 100
H2O2 20μg/mL 2.3 205 +138
H2O2 40μg/mL 6.7 390 +353
H2O2 80μg/mL 7.5 330 +284
H2O2 80μg/mL + L.Arg 8.1 425 +394
H2O2 80μg/mL + L-NAME 1.2 112 +30
Human Plasma 1.1 127 100
Human Plasma + O2 1.2 125 100
Human Plasma + O2O3 20μg/mL 1.7 215 +72
Human Plasma + O2O3 40μg/mL 3.5 290 +132
Human Plasma + O2O3 60μg/mL 4.7 320 +156
Human Plasma + O2O3 80μg/mL 4.2 270 +116
Human Plasma + O2O3 80μg/mL + L-NAME 0.9 149 +19
1 All values are of the average of two determinations.
group) or in the presence of the mentioned inducers. After
treatment, cells were washed twice with phosphate-buﬀered
saline, scraped with a rubber policeman, and pelleted at
2500g for 10minutes. The cell pellet was suspended in
MgCl2 (2mM) phosphate (100mM) buﬀer (pH 7.4), frozen
at −80◦C,thawedthreetimes tobreakupthecellmembrane,
and ﬁnally sonicated in ice before centrifugation at 18000g
for 10 minutes at 4◦C. 10μL was taken to determine pro-
tein concentration [24]. The ﬁnal supernatant was added to
the reaction mixture (400μL) containing 3mg protein of rat
liver cytosol prepared from 105000g supernatant fraction as
a source of biliverdin reductase, 20μmol/L hemin, 2mmol/L
glucose6-phosphate,0.2unitsglucose6-phosphatedehydro-
genase, and 0.8mmol/L β-NADPH. The reaction was con-
ducted for 1 hour at 37◦C in the dark and terminated by
the addition of 1mL chloroform. The extracted bilirubin
was calculated by the diﬀerence in absorption between 464
and 530nm using a quartz cuvette (extinction coeﬃcient,
40mM−1· cm−1 for bilirubin). HO-1 activity was expressed
as picomoles of bilirubin formed per milligram of endothe-
lial cell protein per hour [24].
2.7. Westernblotanalysis
Cells were harvested and lysed in appropriate buﬀer contain-
ing 1% Triton X-100. Equal amounts of proteins, which were
determinedusingakitfromPierce(Rockford,Ill,USA),were
resolved by SDS-polyacrylamide gel electrophoresis, trans-
ferred to PVDF ﬁlters and subjected to immunoblot using
speciﬁc antibodies against HO-1 (StressGen Biotechnolo-
gies, Canada), Hsp-70 (BD Biosciences, San Jose, CA, USA),
and β-actin (Cell Signaling Technology, Beverly, MA, USA).
Membranes were incubated with an appropriate peroxidase-
conjugated secondary antibody, and the antigen-antibody
complexes were visualized using an Immuno-Star HRP kit
(Bio-Rad Laboratories, Hercules, CA, USA). Nonsaturated-
immunoreactive bands were detected with a CCD camera gel
documentation system (ChemiDoc XRS, Bio-Rad Laborato-
ries,CA,USA)and thenquantitatedwithQuantityOnesoft-
ware (Bio-Rad Laboratories). β-actin was used in the same
gel to normalize the amounts of total protein present in the
samples.
2.8. Statisticalevaluation
Owing to a cell contamination, the average values of only
t w os e t so fd a t aa r ep r e s e n t e di nTable 1. Results, although
in good agreement, do not allow a statistical analysis. On the
other hand, Figure 1 has been statistically evaluated and val-
ues are expressed as means and standard deviation. P values
less than .05 were considered signiﬁcant and marked with
one asterisk.
3. RESULTS
Figure 1showsthemodiﬁcationofthelevelsofPTG,TBARS,
and H2O2 in relation to the diﬀerent ozone concentrations.
In previous experiments, we have also measured the total an-
tioxidant status of human plasma that transitorily decreases
to no less than 60% when the ozone concentration is at
80μg/mL per mL of blood. PTG show a progressive decrease
in relation to the ozone dose and the lowest value (53%)
was determined at an ozone concentration of 160μg/mL per
mL of blood. Peroxidation levels were measured as TBARS
increased with the ozone dose and their values ensure the
ozonation eﬃciency. Values remained stable in vitro for sev-
eral hours.
Table 1 shows the results as achieved by evaluating both
NO and the HO-1 activity. After 18-hour incubation, NO
was measured in the culture supernatants while the super-
natants obtained from the cell layers after undergoing the
enzyme extraction [23] were incubated for one hour for
measuring the generation of bilirubin. H2O2 induces both
NO and HO-1, indirectly measured by the production of
bilirubin. As it has been previously observed (23, 25), there
is a good relationship between NO and HO-1: addition of4 Mediators of Inﬂammation
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Figure 1: Eﬀect of either oxygenation (O2)o ro z o n a t i o na to z o n e
concentrations of 20, 40, 60, 80, and160μg/mLgas permLofblood
(three blood samples of the same donor collected in heparin). To
one sampleL-NAME,(20mM)was added. The diagramreports the
determinations of protein thiol group (PTG), thiobarbituric acid
reactive substances (TBARS), and H2O2. The statistical signiﬁcance
has been indicated with (∗)
L-arginine (20μM) enhances the production of NO and of
HO-1, while the NO-synthase inhibitor L-NAME (20mM)
strongly depresses the release of the messenger and of the
enzyme. Without L-arginine, a concentration of 40μg/mL
is more eﬀective than the higher concentration of 80μg/mL.
The same trend has been observed with the use of ozonated
human plasma similarly inhibited in the presence of L-
NAME.
Both H2O2 and ozonated human plasma induce an in-
creased production of NO and bilirubin in a dose-dependent
fashion up to noncytotoxic doses. This trend has been con-
ﬁrmed in analyzing, by Western blot, some of the samples;
and in Figure 2, we can note that a medium-level plasma
ozonation (40μg/mL) is the most eﬀective in inducing both
HO-1 and Hsp-70. Interestingly, either the low or the high
doses are less eﬀective. 4-hydroxynonenal was inhibitory
probably because it was cytotoxic at the concentration of
10μM.
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Figure 2: Ozonated human plasma, particularly at the medium
ozone concentration of 40μg/mL per mL of blood activates both
HO-1 and Hsp-70 in human endothelial cells. The signals of both
protein levels were determined by densitometric analysis of the
scanned images. Data are expressed as arbitrary units. One repre-
sentative Western blot of a typical experiment is shown in the top
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4. DISCUSSION
Since Maines’ extensive review [6] on the heme oxygenase
system, its antioxidant and cytoprotective activities have
been amply demonstrated in a variety of pathological con-
ditions [26–34]. It is well recognized that HO-1 is induced
during oxidative stress due to superoxide, hydroxyl radicals,
hypoclorous acid, singlet oxygen, and peroxyl radicals. Fur-
thermore, Motterlini et al. [23] and Wang et al. [25]h a v e
clariﬁed that NO and NO-releasing compounds modulate
theactivityofHO-1.Allofthesecontributionshavebeenim-
portant in explaining why some drugs are able to produce
anti-inﬂammatory and antiproliferative eﬀects most likely
due to HO-1.
For a long time, we have been involved in clarifying the
biological and therapeutic eﬀects of ozone therapy, that in
the classical form, consists in exposing for a few minutes
a volume (100–225mL) of human blood to a mixture of
oxygen-ozone where the latter gas is only 2–4%. However, its
extremely high reactivity causes an acute oxidative stress that
a c t i v a t e san u m b e ro fb i o c h e m i c a lp a t h w a y s[ 10–15] with-
out any deleterious action on HO-1 blood cells, because the
ozone dose is perfectly calibrated against the potent antiox-
idant capacity of plasma and erythrocytes. While we have
shown already the induction of antioxidant enzymes, it re-
mains to demonstrate the production of HO-1. Ozone dis-
solves in the water of plasma and instantaneously reacts with
unsaturated fattyacids and antioxidants and in doing so, dis-
appears but generates H2O2, a variety of alkenals, and a trace
of hemoglobin from no more than 0,7% of the erythrocyte
mass. The evaluation of the ozonated plasma has shown the
consistencyoftheozonationprocess,particularlyinthether-
apeutic range of 0.42μmol/mL (20μg/mL ozone per mL of
plasma) up to 1.68μmol/ mL (80μg/mL ozone).
In Table 1, we compared the production of NO and
HO-1, assessed as bilirubin, because it has been previously
ascertained a consequential eﬀect [23, 25]. We have con-
ﬁrmed this relationship except for the highest ozone dose
(1.68μmol/mL) and when the inhibitor of NO synthase was
present. Moreover, the optimal induction of HO-1 depends
very much from the dose; in fact, H2O2 at concentrations of
100 and 200μg/mL (data not shown) and 4-hydroxynonenal
at a concentration of 10μM have inhibited the induction be-
causetheyaremostlikelycytotoxic.Itremainsunclearwhyin
this experiment heme inhibited the induction of both Hsp-
70 and HO-1. Nonetheless, it appears evident, as we have ob-
served also for the induction of antioxidant enzymes, that
the optimal induction of HO-1 and Hsp-70, at least in vitro,
is achieved by using the medium ozone therapeutic dose
(0.84μmol/mL or 40μg/mL gas per mL of blood). The bio-
chemical data are consistent with the Western blot analysis
and show that both HO-1 and Hsp-70 may play important
protective functions in adaptive responses to oxidative stress
[35, 36]. In addition, the adaptation to oxidative stress in-
duced by O3 treatment has been also shown in animal stud-
ies by Zamora et al. and by Ajamieh et al. [37, 38]. This result
agrees well with the clinical data because the best therapeutic
results have been obtained by starting with low dose up to
medium dose.
A ﬁnal useful comment is that the induction of HO-
1 surprisingly has been obtained by administering simvas-
tatin[39],rosuvastatin[40],aspirin[41],andcurcumin[42],
suggesting the protective activity of this enzyme with other
drugs.
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